The threats your market is facing, answered in 24 hours
200 management questions across AI, pharma, medical devices, semiconductors and future tech. Each Viewpoint is an evidence brief built from public data at a scale no analyst could compile by hand - with our verdict, who is exposed, the signals to watch and what to do next.
- 01
Pick the question
Each Viewpoint answers one management question on a threat, regulation or disruption - search the library below.
- 02
Order in a minute
US$250, paid online. Add a company, region or angle you want it to focus on.
- 03
Receive it within 24 hours
An evidence brief built from public data - trials, approvals, patents, filings, trade and policy records - with our verdict, who is exposed, signals to watch and actions.
200 of 200 Viewpoints
- AIDisruptionNear term (1-3 years)
Will AI agents cut IT-services and BPO revenue by 2028?
This helps buyers understand the potential revenue impact of AI agents on IT services and BPO.
- Who is exposed:
- IT services, Business Process Outsourcing
- For:
- Chief Information Officer, Head of Strategy, IT Procurement
$250 delivered within 24 hours
- AICompetitive threatNear term (1-3 years)
Which enterprise software categories will AI copilots commoditise first?
This helps buyers identify which enterprise software categories are most vulnerable to commoditisation by AI copilots.
- Who is exposed:
- Enterprise software vendors, SaaS providers
- For:
- Chief Product Officer, Head of Strategy, Software Development Lead
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
EU AI Act: which products fall into the high-risk class, and what will compliance cost?
This helps buyers understand which products are high-risk under the EU AI Act and the associated compliance costs.
- Who is exposed:
- AI developers, software companies, hardware manufacturers
- For:
- Chief Legal Officer, Head of Regulatory Affairs, Product Compliance
$250 delivered within 24 hours
- AICapacity & investmentNow (0-12 months)
Are AI data-centre power limits delaying cloud capacity in your region?
This helps buyers assess if AI data centre power limits are impacting cloud capacity in their region.
- Who is exposed:
- Cloud providers, data centre operators, enterprises using cloud
- For:
- Chief Technology Officer, Head of Infrastructure, Data Centre Operations
$250 delivered within 24 hours
- AIGeopolitics & tradeNear term (1-3 years)
Sovereign AI: which countries are funding national AI compute, and who supplies it?
This helps buyers identify countries funding national AI compute and their key technology suppliers.
- Who is exposed:
- Semiconductor manufacturers, cloud providers, AI hardware suppliers
- For:
- Head of Government Affairs, Chief Strategy Officer, Sales Director
$250 delivered within 24 hours
- AIPricing & cost pressureNear term (1-3 years)
Will open-weight AI models erode paid model API pricing?
This helps buyers understand the potential impact of open-weight AI models on paid model API pricing.
- Who is exposed:
- AI model developers, API providers, cloud AI services
- For:
- Chief Product Officer, Head of Monetisation, Strategy Lead
$250 delivered within 24 hours
- AICompetitive threatNow (0-12 months)
AI coding assistants: which developer-tool vendors are most at risk?
This helps buyers identify which developer tool vendors are most at risk from AI coding assistants.
- Who is exposed:
- Developer tool vendors, IDE providers, software development platforms
- For:
- Chief Technology Officer, Head of Product, Software Engineering Manager
$250 delivered within 24 hours
- AISupply chain riskNear term (1-3 years)
GPU supply 2026-2027: who gets capacity and who waits?
This helps buyers understand who will secure GPU capacity and who will face delays in the coming years.
- Who is exposed:
- Cloud providers, AI developers, data centre operators
- For:
- Chief Procurement Officer, Head of Supply Chain, Data Centre Operations
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
AI in customer service: how fast are contact-centre seats being replaced?
This helps buyers assess the speed at which AI is replacing contact centre seats.
- Who is exposed:
- Contact centres, BPO providers, customer service departments
- For:
- Head of Customer Service, Chief Operating Officer, Workforce Planning
$250 delivered within 24 hours
- AICyber & security riskNow (0-12 months)
Deepfakes and synthetic identity fraud: how exposed are banks and insurers?
This helps buyers understand their exposure to deepfakes and synthetic identity fraud.
- Who is exposed:
- Banks, insurance companies, financial institutions
- For:
- Chief Risk Officer, Head of Fraud Prevention, Chief Information Security Officer
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
AI copyright litigation: which business models are legally exposed?
This helps buyers identify which business models are legally exposed to AI copyright litigation.
- Who is exposed:
- Media companies, content platforms, AI developers, creative agencies
- For:
- Chief Legal Officer, Head of Intellectual Property, Business Development
$250 delivered within 24 hours
- AIDemand shiftNow (0-12 months)
AI search answers: how much publisher and e-commerce traffic is at risk?
This helps buyers quantify the traffic risk to publishers and e-commerce from AI search answers.
- Who is exposed:
- Publishers, e-commerce retailers, content creators
- For:
- Head of Digital Strategy, Chief Marketing Officer, SEO Manager
$250 delivered within 24 hours
- AICapacity & investmentNear term (1-3 years)
Liquid cooling for AI racks: which data centres must retrofit?
This helps buyers identify which data centres must retrofit for liquid cooling of AI racks.
- Who is exposed:
- Data centre operators, cloud providers, colocation facilities
- For:
- Head of Data Centre Operations, Infrastructure Manager, Chief Technology Officer
$250 delivered within 24 hours
- AIGeopolitics & tradeNow (0-12 months)
AI chip export controls: which buyers and suppliers are exposed?
This helps buyers understand which buyers and suppliers are exposed to AI chip export controls.
- Who is exposed:
- AI chip manufacturers, cloud providers, AI developers
- For:
- Head of Government Affairs, Chief Legal Officer, Supply Chain Director
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
Agentic commerce: will AI shopping agents bypass retailer websites?
This helps buyers assess if AI shopping agents will bypass retailer websites.
- Who is exposed:
- Retailers, e-commerce platforms, brand manufacturers
- For:
- Chief Marketing Officer, Head of E-commerce, Chief Strategy Officer
$250 delivered within 24 hours
- AITechnology shiftLong term (3+ years)
AI in drug discovery: are AI-designed molecules reaching the clinic faster?
This helps buyers determine if AI-designed molecules are reaching clinical trials faster.
- Who is exposed:
- Pharmaceutical companies, biotech firms, contract research organisations
- For:
- Head of R&D, Chief Scientific Officer, Business Development
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
AI governance tools: which regulations are creating mandatory demand?
This helps buyers identify which regulations are driving mandatory demand for AI governance tools.
- Who is exposed:
- AI developers, enterprises using AI, software vendors
- For:
- Chief Compliance Officer, Head of AI Ethics, Chief Legal Officer
$250 delivered within 24 hours
- AICompetitive threatNear term (1-3 years)
On-device small language models: which chip and handset makers win?
This helps buyers identify which chip and handset makers are gaining an advantage with on-device small language models.
- Who is exposed:
- Chip manufacturers, handset makers, consumer electronics brands
- For:
- Chief Technology Officer, Head of Product Development, Strategy Lead
$250 delivered within 24 hours
- AICyber & security riskNow (0-12 months)
AI-driven cyberattacks: which sectors face the steepest rise in risk?
This helps buyers identify which sectors face the steepest rise in risk from AI-driven cyberattacks.
- Who is exposed:
- All sectors, critical infrastructure, financial services, healthcare
- For:
- Chief Information Security Officer, Chief Risk Officer, Head of Security Operations
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
AI hallucination liability: where is the legal risk for enterprises?
This helps buyers understand where the legal risk lies for enterprises regarding AI hallucination liability.
- Who is exposed:
- Enterprises using AI, AI developers, legal firms
- For:
- Chief Legal Officer, Chief Risk Officer, Head of Compliance
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
AI in legal services: which tasks and firms are automated first?
This helps buyers identify which legal tasks and firms are being automated first by AI.
- Who is exposed:
- Law firms, corporate legal departments, legal tech providers
- For:
- Managing Partner, Head of Legal Operations, Chief Innovation Officer
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
AI in accounting and audit: which services lose fee volume?
This helps buyers identify which accounting and audit services will experience fee volume loss due to AI.
- Who is exposed:
- Accounting firms, audit firms, corporate finance departments
- For:
- Chief Financial Officer, Head of Audit, Managing Partner
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
Robotaxi rollout: which cities and fleets are scaling, and who loses?
This helps buyers understand which cities and fleets are scaling robotaxi services and who will lose market share.
- Who is exposed:
- Ride-hailing companies, taxi services, automotive manufacturers, public transport
- For:
- Chief Strategy Officer, Head of Urban Planning, Fleet Manager
$250 delivered within 24 hours
- AITechnology shiftNear term (1-3 years)
AI in radiology: which imaging tasks are automated and reimbursed?
This helps buyers identify which imaging tasks are being automated and reimbursed with AI in radiology.
- Who is exposed:
- Radiology departments, hospitals, medical imaging companies
- For:
- Chief Medical Officer, Head of Radiology, Hospital Administrator
$250 delivered within 24 hours
- AICapacity & investmentNear term (1-3 years)
AI electricity demand: will utility grid upgrades keep pace?
This helps buyers assess if utility grid upgrades can keep pace with AI electricity demand.
- Who is exposed:
- Utility companies, grid operators, data centre developers
- For:
- Head of Grid Planning, Chief Operating Officer, Energy Procurement
$250 delivered within 24 hours
- AITalent & labourNow (0-12 months)
AI talent costs: which roles see the steepest wage inflation?
This helps buyers understand where to focus recruitment and retention efforts for critical AI roles.
- Who is exposed:
- Technology services, software development, data science, AI research
- For:
- Chief Human Resources Officer, Head of Talent Acquisition, CTO
$250 delivered within 24 hours
- AITechnology shiftNear term (1-3 years)
AI in insurance underwriting: which lines are being repriced?
This helps buyers identify which insurance lines are being repriced due to AI adoption and adjust strategies.
- Who is exposed:
- Property and casualty insurance, life insurance, health insurance
- For:
- Chief Underwriting Officer, Head of Product, Chief Data Officer
$250 delivered within 24 hours
- AITechnology shiftNow (0-12 months)
AI visual inspection: which factories are replacing manual quality checks?
This helps buyers understand where AI visual inspection is replacing manual quality checks to optimize production.
- Who is exposed:
- Automotive manufacturing, electronics manufacturing, food processing, pharmaceuticals
- For:
- Head of Operations, Plant Manager, Chief Technology Officer
$250 delivered within 24 hours
- AIRegulation & policyNear term (1-3 years)
Data-centre water use: which sites face permitting risk?
This helps buyers identify data centre sites facing permitting risks due to water usage regulations and plan accordingly.
- Who is exposed:
- Hyperscale data centres, colocation providers, cloud computing
- For:
- Chief Sustainability Officer, Head of Infrastructure, General Counsel
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
US state AI laws: which rules affect your product?
This helps buyers understand which US state AI laws affect their products to ensure compliance and avoid penalties.
- Who is exposed:
- AI software developers, technology companies, legal services
- For:
- Chief Legal Officer, Head of Product, Chief Compliance Officer
$250 delivered within 24 hours
- AICompetitive threatNear term (1-3 years)
Custom AI ASICs: which programmes threaten merchant GPU vendors?
This helps buyers assess which custom AI ASIC programs pose a threat to merchant GPU vendors and adjust market strategies.
- Who is exposed:
- GPU manufacturers, semiconductor foundries, AI hardware startups
- For:
- Chief Strategy Officer, Head of Product, Investor Relations
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
Edge AI cameras: privacy rules versus surveillance demand by country
This helps buyers navigate the balance between privacy rules and surveillance demand for edge AI cameras by country.
- Who is exposed:
- Security camera manufacturers, smart city developers, retail technology
- For:
- Chief Privacy Officer, Head of Product, General Counsel
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
Generative AI in advertising: will creative agencies lose budgets?
This helps buyers understand if generative AI will lead to budget cuts for creative agencies and adapt business models.
- Who is exposed:
- Creative agencies, marketing departments, content creators
- For:
- Chief Marketing Officer, Head of Creative, Chief Strategy Officer
$250 delivered within 24 hours
- AICompetitive threatNow (0-12 months)
AI tutoring: which education companies are losing subscribers?
This helps buyers identify which education companies are losing subscribers to AI tutoring and refine competitive strategies.
- Who is exposed:
- Online education providers, tutoring services, textbook publishers
- For:
- Chief Strategy Officer, Head of Product, Investor Relations
$250 delivered within 24 hours
- AITechnology shiftNear term (1-3 years)
AI in banking compliance: which KYC and AML vendors are displaced?
This helps buyers understand which KYC and AML vendors are being displaced by AI in banking compliance.
- Who is exposed:
- KYC vendors, AML vendors, financial institutions
- For:
- Chief Compliance Officer, Head of Risk Management, Chief Technology Officer
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
Synthetic data: will it replace data-labelling services?
This helps buyers assess if synthetic data will replace traditional data labelling services and adjust sourcing strategies.
- Who is exposed:
- Data labelling services, data annotation providers, AI training data
- For:
- Chief Data Officer, Head of AI/ML, Procurement Manager
$250 delivered within 24 hours
- AIDemand shiftNow (0-12 months)
AI PCs and smartphones: is the replacement cycle real?
This helps buyers determine if the AI PC and smartphone replacement cycle is real to inform product and sales strategies.
- Who is exposed:
- PC manufacturers, smartphone manufacturers, semiconductor companies
- For:
- Chief Marketing Officer, Head of Product, Investor Relations
$250 delivered within 24 hours
- AIRegulation & policyNow (0-12 months)
AI training-data licensing: who is paying whom, and how much?
This helps buyers understand the landscape of AI training data licensing, including who is paying whom and how much.
- Who is exposed:
- AI model developers, data providers, content creators
- For:
- Chief Legal Officer, Head of AI/ML, Chief Procurement Officer
$250 delivered within 24 hours
- AITechnology shiftNear term (1-3 years)
Humanoid robots: which pilots are moving to paid deployments?
This helps buyers identify which humanoid robot pilot programs are transitioning to paid deployments to assess market readiness.
- Who is exposed:
- Logistics, manufacturing, healthcare, retail
- For:
- Head of Operations, Chief Technology Officer, Procurement Manager
$250 delivered within 24 hours
- AITechnology shiftNear term (1-3 years)
AI in chip design: how fast is design automation shortening tape-outs?
This helps buyers understand how fast AI in chip design is shortening tape-out times to optimize development cycles.
- Who is exposed:
- Chip design companies, EDA tool vendors, semiconductor foundries
- For:
- Chief Technology Officer, Head of Engineering, VP of R&D
$250 delivered within 24 hours
- AICyber & security riskNow (0-12 months)
AI incidents: which industries report the most AI failures?
This helps buyers identify which industries report the most AI failures to benchmark risks and improve reliability.
- Who is exposed:
- Financial services, healthcare, automotive, technology
- For:
- Chief Risk Officer, Chief Information Security Officer, Head of AI Ethics
$250 delivered within 24 hours
- AICapacity & investmentNear term (1-3 years)
Data-centre construction pipeline: which regions are overbuilt or short?
This helps buyers identify regions with overbuilt or short data centre capacity to inform investment and expansion plans.
- Who is exposed:
- Data centre operators, real estate developers, cloud providers
- For:
- Head of Infrastructure, Chief Investment Officer, Real Estate Director
$250 delivered within 24 hours
- AITechnology shiftNear term (1-3 years)
AI agents in finance back offices: which processes go first?
This helps buyers understand which financial back-office processes are being automated by AI agents first.
- Who is exposed:
- Banking, insurance, asset management, fintech
- For:
- Chief Operating Officer, Head of Digital Transformation, Chief Technology Officer
$250 delivered within 24 hours
- AICapacity & investmentLong term (3+ years)
Nuclear power deals for AI data centres: who signed what?
This helps buyers identify who is signing nuclear power deals for AI data centres to understand energy sourcing trends.
- Who is exposed:
- Nuclear power generators, data centre operators, energy utilities
- For:
- Chief Investment Officer, Head of Energy Procurement, Chief Strategy Officer
$250 delivered within 24 hours
- AIDisruptionNear term (1-3 years)
Co-packaged optics: will it disrupt pluggable transceiver makers?
This helps buyers assess if co-packaged optics will disrupt pluggable transceiver makers and adjust product roadmaps.
- Who is exposed:
- Pluggable transceiver manufacturers, optical component suppliers, data centre networking
- For:
- Chief Technology Officer, Head of Product, Investor Relations
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftNear term (1-3 years)
GLP-1 drugs beyond obesity: which industries are next?
This helps buyers identify which industries are next to be impacted by GLP-1 drugs beyond obesity.
- Who is exposed:
- Food and beverage, medical devices, healthcare services, fitness
- For:
- Chief Strategy Officer, Head of Market Research, Investor Relations
$250 delivered within 24 hours
- Pharma & BiotechPatent & exclusivity lossNear term (1-3 years)
The 2026-2030 biosimilar wave: which biologics lose exclusivity?
This helps buyers identify which biologics will lose exclusivity in the biosimilar wave to prepare for market changes.
- Who is exposed:
- Originator biologic manufacturers, generic drug companies, healthcare payers
- For:
- Head of Portfolio Strategy, Chief Commercial Officer, Investor Relations
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNow (0-12 months)
US drug price negotiation: which drugs and companies are hit next?
This helps buyers identify which drugs and companies are next to be hit by US drug price negotiation.
- Who is exposed:
- Pharmaceutical manufacturers, biotech companies, healthcare providers
- For:
- Chief Government Affairs Officer, Head of Market Access, Chief Financial Officer
$250 delivered within 24 hours
- Pharma & BiotechSupply chain riskNow (0-12 months)
Generic drug shortages: which molecules are at risk of supply failure?
This helps buyers identify which generic drug molecules are at risk of supply failure to mitigate shortages.
- Who is exposed:
- Generic drug manufacturers, hospitals, pharmacies, healthcare systems
- For:
- Head of Supply Chain, Chief Procurement Officer, Chief Medical Officer
$250 delivered within 24 hours
- Pharma & BiotechGeopolitics & tradeNear term (1-3 years)
China biotech licensing: are Western pipelines becoming China-sourced?
This helps buyers assess if Western pipelines are becoming China-sourced through biotech licensing deals.
- Who is exposed:
- Western pharmaceutical companies, Chinese biotech firms, venture capital
- For:
- Chief Business Development Officer, Head of R&D, Chief Strategy Officer
$250 delivered within 24 hours
- Pharma & BiotechGeopolitics & tradeNow (0-12 months)
Restrictions on Chinese CDMOs: how exposed is US pharma?
This helps buyers understand their supply chain vulnerability to geopolitical tensions and make informed sourcing decisions.
- Who is exposed:
- US pharmaceutical companies, contract development manufacturing organizations
- For:
- Chief Procurement Officer, Head of Supply Chain, Government Affairs
$250 delivered within 24 hours
- Pharma & BiotechTechnology shiftNear term (1-3 years)
Oral GLP-1s: will pills displace injectables?
This helps buyers anticipate market shifts and adapt product strategies for diabetes and obesity treatments.
- Who is exposed:
- Injectable GLP-1 manufacturers, pharmaceutical companies, diabetes care providers
- For:
- Chief Commercial Officer, Head of R&D, Product Manager
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftNow (0-12 months)
Cell and gene therapy launches: are they meeting expectations?
This helps buyers assess the commercial viability and market adoption of advanced therapeutic medicinal products.
- Who is exposed:
- Cell therapy developers, gene therapy developers, biotech investors, healthcare providers
- For:
- Head of Commercial Strategy, Investor Relations, R&D Director
$250 delivered within 24 hours
- Pharma & BiotechCompetitive threatNear term (1-3 years)
Antibody-drug conjugates: is the deal wave creating a crowded field?
This helps buyers understand the competitive landscape and identify strategic opportunities or risks in oncology.
- Who is exposed:
- Oncology drug developers, biotech companies, pharmaceutical investors
- For:
- Head of Business Development, R&D Director, Chief Strategy Officer
$250 delivered within 24 hours
- Pharma & BiotechPatent & exclusivity lossLong term (3+ years)
Patent cliff 2027-2032: which top drugs lose protection?
This helps buyers identify key drugs losing patent protection and plan for market entry or competitive strategies.
- Who is exposed:
- Branded pharmaceutical companies, generic drug manufacturers, pharmaceutical investors
- For:
- Chief Strategy Officer, Head of Portfolio Management, Business Development Director
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNow (0-12 months)
Most-favoured-nation drug pricing: exposure by company
This helps buyers understand the financial impact of drug pricing policies on their product portfolios.
- Who is exposed:
- Pharmaceutical manufacturers, drug distributors, healthcare providers
- For:
- Head of Government Affairs, Market Access Director, Chief Financial Officer
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftNow (0-12 months)
Alzheimer's therapies: is uptake of amyloid drugs growing?
This helps buyers understand the market acceptance and growth trajectory of new Alzheimer's treatments.
- Who is exposed:
- Alzheimer's drug manufacturers, neurology clinics, healthcare systems
- For:
- Chief Medical Officer, Head of Commercial Strategy, Market Access Director
$250 delivered within 24 hours
- Pharma & BiotechSupply chain riskNow (0-12 months)
Radiopharmaceuticals: is isotope supply the bottleneck?
This helps buyers identify potential supply bottlenecks and ensure continuity for critical medical isotopes.
- Who is exposed:
- Radiopharmaceutical companies, nuclear medicine providers, diagnostic imaging centers
- For:
- Chief Procurement Officer, Head of Supply Chain, R&D Director
$250 delivered within 24 hours
- Pharma & BiotechCompetitive threatNear term (1-3 years)
mRNA beyond COVID: which pipelines survive?
This helps buyers identify promising mRNA pipelines beyond COVID and allocate resources effectively.
- Who is exposed:
- mRNA vaccine developers, therapeutic mRNA companies, biotech investors
- For:
- Head of R&D, Chief Strategy Officer, Investor Relations
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNear term (1-3 years)
Psychedelic therapies: regulatory path and commercial readiness
This helps buyers navigate the regulatory landscape and assess the commercial readiness of psychedelic therapies.
- Who is exposed:
- Psychedelic drug developers, mental health providers, biotech investors
- For:
- Head of Regulatory Affairs, Chief Commercial Officer, R&D Director
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftLong term (3+ years)
Antimicrobial resistance: which pull incentives create a market?
This helps buyers understand which incentives can stimulate the development of new antimicrobials.
- Who is exposed:
- Antibiotic developers, public health organizations, pharmaceutical policy makers
- For:
- Head of Government Affairs, Market Access Director, R&D Director
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNow (0-12 months)
GLP-1 compounding crackdown: what happens to compounding pharmacies?
This helps buyers understand the impact of regulatory crackdowns on compounding pharmacies and market dynamics.
- Who is exposed:
- Compounding pharmacies, GLP-1 manufacturers, regulatory bodies
- For:
- Chief Legal Officer, Head of Regulatory Affairs, Pharmacy Director
$250 delivered within 24 hours
- Pharma & BiotechCapacity & investmentNow (0-12 months)
Biologics CDMO capacity: shortage or glut?
This helps buyers assess the current state of biologics manufacturing capacity to inform investment and outsourcing decisions.
- Who is exposed:
- Biologics manufacturers, CDMOs, biotech companies
- For:
- Chief Operating Officer, Head of Manufacturing, Supply Chain Director
$250 delivered within 24 hours
- Pharma & BiotechPricing & cost pressureNow (0-12 months)
Rare disease drug pricing: are payers pushing back?
This helps buyers understand payer sentiment and adjust pricing strategies for orphan drugs.
- Who is exposed:
- Rare disease drug manufacturers, payers, healthcare systems
- For:
- Market Access Director, Head of Government Affairs, Chief Commercial Officer
$250 delivered within 24 hours
- Pharma & BiotechGeopolitics & tradeNow (0-12 months)
Pharmaceutical tariffs: how exposed are drug supply chains?
This helps buyers assess the vulnerability of drug supply chains to tariffs and plan mitigation strategies.
- Who is exposed:
- Pharmaceutical supply chains, drug manufacturers, distributors
- For:
- Chief Procurement Officer, Head of Supply Chain, Government Affairs
$250 delivered within 24 hours
- Pharma & BiotechSupply chain riskNow (0-12 months)
API sourcing from India and China: concentration risk by molecule
This helps buyers identify concentration risks in API sourcing and diversify their supply base.
- Who is exposed:
- Pharmaceutical manufacturers, generic drug companies, API suppliers
- For:
- Chief Procurement Officer, Head of Supply Chain, Risk Management Director
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftNow (0-12 months)
Obesity drug coverage: which insurers and employers are dropping it?
This helps buyers understand the evolving landscape of obesity drug coverage and adjust market strategies.
- Who is exposed:
- Obesity drug manufacturers, health insurers, employers
- For:
- Market Access Director, Chief Commercial Officer, Head of Payer Relations
$250 delivered within 24 hours
- Pharma & BiotechCapacity & investmentNow (0-12 months)
Peptide manufacturing capacity: can supply meet GLP-1 demand?
This helps buyers assess if peptide manufacturing capacity can meet the surging demand for GLP-1 drugs.
- Who is exposed:
- Peptide manufacturers, GLP-1 drug developers, CDMOs
- For:
- Chief Operating Officer, Head of Manufacturing, Supply Chain Director
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNow (0-12 months)
Vaccine policy shifts: what happens to vaccine demand?
This helps buyers anticipate changes in vaccine demand due to evolving public health policies.
- Who is exposed:
- Vaccine manufacturers, public health organizations, healthcare providers
- For:
- Head of Government Affairs, Chief Commercial Officer, Public Health Director
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNear term (1-3 years)
Real-world evidence: which regulators accept it for approvals?
This helps buyers understand regulatory acceptance of real-world evidence for drug approvals and market access.
- Who is exposed:
- Pharmaceutical companies, regulatory agencies, contract research organizations
- For:
- Head of Regulatory Affairs, R&D Director, Chief Medical Officer
$250 delivered within 24 hours
- Pharma & BiotechTechnology shiftNow (0-12 months)
Decentralised clinical trials: adoption after the pandemic peak
This helps buyers assess the sustained adoption of decentralized clinical trials post-pandemic and optimize trial design.
- Who is exposed:
- Pharmaceutical companies, contract research organizations, technology providers
- For:
- Head of Clinical Operations, R&D Director, Chief Digital Officer
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftNear term (1-3 years)
Long-acting injectables in psychiatry and HIV: switching dynamics
This helps buyers understand patient and prescriber switching dynamics for long-acting injectables in key therapeutic areas.
- Who is exposed:
- Psychiatry drug manufacturers, HIV drug manufacturers, healthcare providers
- For:
- Chief Commercial Officer, Market Access Director, R&D Director
$250 delivered within 24 hours
- Pharma & BiotechCapacity & investmentNow (0-12 months)
Biotech funding: which therapeutic areas still raise capital?
This helps buyers identify therapeutic areas that continue to attract significant capital investment in biotech.
- Who is exposed:
- Biotech companies, venture capital firms, pharmaceutical investors
- For:
- Chief Financial Officer, Head of Business Development, Investor Relations
$250 delivered within 24 hours
- Pharma & BiotechTechnology shiftNow (0-12 months)
Pharma AI partnerships: who is spending, and on what?
Decide where to invest in AI partnerships for drug discovery and development.
- Who is exposed:
- Biotech startups, pharmaceutical companies, contract research organizations
- For:
- Chief Scientific Officer, Head of R&D, Business Development Lead
$250 delivered within 24 hours
- Pharma & BiotechDisruptionNear term (1-3 years)
Microbiome therapeutics: commercial reality after the first approvals
Assess the commercial viability and market potential of microbiome therapies after initial regulatory approvals.
- Who is exposed:
- Biopharmaceutical companies, gastroenterology specialists, infectious disease specialists
- For:
- Chief Medical Officer, Head of Commercial Strategy, R&D Director
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNear term (1-3 years)
CRISPR gene-editing therapies: pricing and patient access
Formulate pricing strategies and patient access programs for novel gene-editing treatments.
- Who is exposed:
- Gene therapy developers, rare disease specialists, health insurers
- For:
- Head of Market Access, Reimbursement Director, Policy Analyst
$250 delivered within 24 hours
- Pharma & BiotechDemand shiftNear term (1-3 years)
Weight-loss drugs versus bariatric surgery: which procedures decline?
Anticipate changes in bariatric surgery volumes due to the rise of new weight-loss medications.
- Who is exposed:
- Bariatric surgery centers, medical device manufacturers, hospital systems
- For:
- Hospital Administrator, Surgical Department Head, Medical Device Product Manager
$250 delivered within 24 hours
- Pharma & BiotechPricing & cost pressureNow (0-12 months)
Oncology biosimilars: how low will European tender prices go?
Understand the competitive pricing dynamics and potential for price erosion in European oncology biosimilar markets.
- Who is exposed:
- Biologics manufacturers, pharmaceutical distributors, healthcare providers
- For:
- Head of Market Access, Procurement Director, Commercial Strategy Lead
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNow (0-12 months)
Drug serialisation deadlines: who is not ready?
Identify compliance gaps and risks related to upcoming drug serialisation deadlines.
- Who is exposed:
- Pharmaceutical manufacturers, contract manufacturing organizations, distributors
- For:
- Head of Supply Chain, Regulatory Affairs Director, Operations Manager
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNear term (1-3 years)
Medicare Part D redesign: effects on specialty drug makers
Evaluate the financial and market access implications of Medicare Part D reforms for specialty drug portfolios.
- Who is exposed:
- Specialty drug manufacturers, pharmacy benefit managers, pharmacies
- For:
- Head of Government Affairs, Market Access Director, Reimbursement Strategy Lead
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNow (0-12 months)
Pharmacy benefit manager reform: who wins and who loses?
Identify potential winners and losers from proposed reforms to pharmacy benefit manager practices.
- Who is exposed:
- Pharmacy benefit managers, pharmaceutical manufacturers, retail pharmacies
- For:
- Head of Policy, Government Affairs Director, Business Development Lead
$250 delivered within 24 hours
- Pharma & BiotechRegulation & policyNear term (1-3 years)
EU pharmaceutical law reform: what changes for exclusivity?
Prepare for changes in market exclusivity periods and intellectual property protection under new EU pharmaceutical laws.
- Who is exposed:
- Pharmaceutical companies, biotech firms, generic drug manufacturers
- For:
- Head of Regulatory Affairs, Legal Counsel, Market Access Director
$250 delivered within 24 hours
- Pharma & BiotechCompetitive threatNow (0-12 months)
Bispecific antibodies: how crowded are the immuno-oncology targets?
Assess the competitive landscape and identify crowded or underserved targets in immuno-oncology for bispecific antibodies.
- Who is exposed:
- Oncology drug developers, immunotherapy companies, contract research organizations
- For:
- Chief Scientific Officer, Head of R&D, Business Development Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftNear term (1-3 years)
GLP-1 drugs and sleep apnea: how exposed are CPAP makers?
Understand the potential impact of GLP-1 drugs on the demand for CPAP devices for sleep apnea.
- Who is exposed:
- CPAP device manufacturers, sleep clinics, respiratory therapists
- For:
- Product Manager, Business Development Lead, Clinical Director
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
FDA device recalls: which product categories are trending up?
Identify trending product categories in FDA device recalls to proactively address quality and safety issues.
- Who is exposed:
- Medical device manufacturers, quality assurance departments, regulatory affairs
- For:
- Head of Quality, Regulatory Affairs Director, Risk Management Officer
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
EU MDR certification backlog: which devices risk withdrawal?
Identify medical devices at risk of market withdrawal due to the EU MDR certification backlog.
- Who is exposed:
- Medical device manufacturers, regulatory consultants, distributors
- For:
- Regulatory Affairs Director, Head of Compliance, Product Portfolio Manager
$250 delivered within 24 hours
- Medical Devices & HealthcareCompetitive threatNow (0-12 months)
Robotic surgery competition: is the leader's moat eroding?
Evaluate the competitive landscape in robotic surgery and assess the erosion of market leader advantages.
- Who is exposed:
- Surgical robotics manufacturers, hospital systems, surgical instrument suppliers
- For:
- Head of Strategy, Product Development Lead, Business Development Manager
$250 delivered within 24 hours
- Medical Devices & HealthcareDisruptionNear term (1-3 years)
Over-the-counter glucose monitors: new buyers and margins
Understand the new buyer segments and margin implications for over-the-counter glucose monitoring devices.
- Who is exposed:
- Diabetes device manufacturers, pharmacies, health retailers
- For:
- Head of Commercial Strategy, Product Manager, Retail Partnerships Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Hospital-at-home: which reimbursement waivers keep it alive?
Identify which reimbursement waivers are crucial for the continued viability of hospital-at-home programs.
- Who is exposed:
- Hospital systems, home healthcare providers, medical device companies
- For:
- Hospital Administrator, Head of Innovation, Policy Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Remote patient monitoring billing scrutiny: who is exposed?
Assess the risks associated with increased billing scrutiny for remote patient monitoring services.
- Who is exposed:
- Remote patient monitoring providers, telehealth companies, healthcare systems
- For:
- Compliance Officer, Revenue Cycle Manager, Legal Counsel
$250 delivered within 24 hours
- Medical Devices & HealthcareCyber & security riskNow (0-12 months)
Medical device cybersecurity rules: what regulators now require
Understand the evolving regulatory requirements for medical device cybersecurity and ensure compliance.
- Who is exposed:
- Medical device manufacturers, hospital IT departments, cybersecurity firms
- For:
- Chief Information Security Officer, Regulatory Affairs Director, Product Development Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Wearable health claims: which features are being regulated?
Identify which health features in wearables are attracting regulatory attention and requiring medical device classification.
- Who is exposed:
- Wearable device manufacturers, health tech startups, consumer electronics companies
- For:
- Regulatory Affairs Director, Product Development Lead, Legal Counsel
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftLong term (3+ years)
Dialysis demand: will new kidney-protective drugs reduce it?
Anticipate changes in dialysis demand due to the introduction of new kidney-protective medications.
- Who is exposed:
- Dialysis providers, kidney disease device manufacturers, nephrology clinics
- For:
- Clinical Director, Business Development Lead, Hospital Administrator
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftLong term (3+ years)
Orthopaedic implants: will weight-loss drugs change surgery volumes?
Assess the potential impact of weight-loss drugs on the volume of orthopaedic implant surgeries.
- Who is exposed:
- Orthopaedic implant manufacturers, orthopaedic surgeons, hospital systems
- For:
- Product Manager, Head of Commercial Strategy, Surgical Department Head
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Laboratory-developed test rules: what changes for diagnostic labs?
Prepare for new regulatory oversight and compliance requirements for laboratory-developed tests.
- Who is exposed:
- Diagnostic laboratories, in vitro diagnostics manufacturers, pathology groups
- For:
- Laboratory Director, Regulatory Affairs Director, Compliance Officer
$250 delivered within 24 hours
- Medical Devices & HealthcareTechnology shiftNow (0-12 months)
AI medical device clearances: which specialties lead?
Identify leading medical specialties for AI device clearances to inform product development and market entry strategies.
- Who is exposed:
- Medical device manufacturers, AI software developers, healthcare providers
- For:
- Head of R&D, Product Development Lead, Chief Medical Officer
$250 delivered within 24 hours
- Medical Devices & HealthcareGeopolitics & tradeNow (0-12 months)
Tariffs on medical devices and components from China
Assess the impact of tariffs on medical devices and components imported from China on supply chain costs and strategy.
- Who is exposed:
- Medical device manufacturers, component suppliers, healthcare distributors
- For:
- Head of Supply Chain, Procurement Director, Government Affairs Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareSupply chain riskNow (0-12 months)
Ethylene oxide sterilisation rules: supply risk for devices
Evaluate supply chain risks for medical devices due to evolving ethylene oxide sterilisation regulations.
- Who is exposed:
- Medical device manufacturers, contract sterilisation providers, hospital systems
- For:
- Head of Supply Chain, Operations Manager, Regulatory Affairs Director
$250 delivered within 24 hours
- Medical Devices & HealthcareDisruptionNow (0-12 months)
Over-the-counter hearing aids: how is the retail channel shifting?
Understand the evolving retail landscape and identify new opportunities or threats from over-the-counter hearing aids.
- Who is exposed:
- Audiology clinics, traditional hearing aid manufacturers, pharmacies, consumer electronics retailers
- For:
- Product Manager, Strategy Director, Business Development Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftNear term (1-3 years)
Point-of-care diagnostics after COVID: who is still growing?
Identify growth segments and opportunities in the point-of-care diagnostics market post-pandemic.
- Who is exposed:
- Diagnostic manufacturers, clinical laboratories, urgent care centers, primary care providers
- For:
- Market Analyst, Investment Manager, Business Strategist
$250 delivered within 24 hours
- Medical Devices & HealthcarePricing & cost pressureNow (0-12 months)
Hospital capital budgets: which equipment purchases are cut?
Understand which equipment categories are most vulnerable to hospital budget cuts to adjust sales strategies.
- Who is exposed:
- Medical equipment manufacturers, healthcare technology providers, hospital systems
- For:
- Sales Director, Product Manager, Financial Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareTalent & labourNear term (1-3 years)
Nurse shortages: demand for automation and staffing technology
Assess the market demand for automation and staffing solutions driven by nurse shortages.
- Who is exposed:
- Hospital systems, nursing homes, home healthcare agencies, medical device companies
- For:
- Operations Director, HR Director, Technology Strategist
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Telehealth reimbursement cliffs: who is exposed?
Identify which telehealth services and providers face revenue risk from changes in reimbursement policies.
- Who is exposed:
- Telehealth providers, remote patient monitoring companies, digital health platforms
- For:
- Policy Analyst, Business Development Manager, Legal Counsel
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftNear term (1-3 years)
Digital therapeutics: what do payers actually cover?
Determine the extent of payer coverage for digital therapeutics to inform market entry and pricing strategies.
- Who is exposed:
- Digital therapeutics developers, pharmaceutical companies, healthcare providers
- For:
- Market Access Manager, Product Manager, Business Development
$250 delivered within 24 hours
- Medical Devices & HealthcareSupply chain riskNear term (1-3 years)
Helium shortages: how exposed are MRI fleets?
Assess the impact of helium shortages on MRI fleet operations and identify mitigation strategies.
- Who is exposed:
- MRI manufacturers, hospital radiology departments, industrial gas suppliers
- For:
- Supply Chain Manager, Procurement Director, Hospital Administrator
$250 delivered within 24 hours
- Medical Devices & HealthcareDisruptionNear term (1-3 years)
Diabetes devices after GLP-1: insulin pumps and monitors
Understand the evolving demand for insulin pumps and monitors in the context of GLP-1 drug adoption.
- Who is exposed:
- Insulin pump manufacturers, continuous glucose monitor companies, diabetes management platforms
- For:
- Product Manager, Strategy Director, Investment Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareCompetitive threatNear term (1-3 years)
Structural heart devices: how competitive is TAVR becoming?
Evaluate the increasing competition in the TAVR market to inform strategic planning and product development.
- Who is exposed:
- Structural heart device manufacturers, cardiovascular surgeons, hospital cath labs
- For:
- Product Manager, Business Development Lead, Market Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftNow (0-12 months)
Surgical backlogs: which procedures are still delayed?
Identify which surgical procedures continue to face delays to optimize resource allocation and sales efforts.
- Who is exposed:
- Hospitals, surgical centers, medical device manufacturers, anesthesia providers
- For:
- Operations Director, Sales Manager, Hospital Administrator
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Private equity in healthcare services: the regulatory backlash
Understand the regulatory scrutiny facing private equity investments in healthcare services to mitigate risks.
- Who is exposed:
- Private equity firms, healthcare service providers, hospital systems, physician groups
- For:
- Legal Counsel, Investment Manager, Compliance Officer
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Medicaid cuts: which providers' revenue is exposed?
Identify which healthcare providers are most vulnerable to revenue loss from Medicaid funding reductions.
- Who is exposed:
- Hospitals, community health centers, nursing homes, behavioral health providers
- For:
- CFO, Revenue Cycle Manager, Policy Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareGeopolitics & tradeNow (0-12 months)
China's volume-based procurement: which foreign device makers lose share?
Identify foreign device makers losing market share due to China's volume-based procurement policies.
- Who is exposed:
- Foreign medical device manufacturers, multinational pharmaceutical companies
- For:
- International Sales Director, Market Access Manager, Strategy Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNear term (1-3 years)
Single-use versus reusable devices: sustainability rules
Understand the regulatory push for sustainable medical devices and its impact on single-use versus reusable products.
- Who is exposed:
- Medical device manufacturers, hospitals, surgical centers, waste management companies
- For:
- Sustainability Officer, Product Development Lead, Procurement Manager
$250 delivered within 24 hours
- Medical Devices & HealthcareCapacity & investmentNear term (1-3 years)
Plasma collection capacity: can supply meet therapy demand?
Assess if current plasma collection capacity can meet the growing demand for plasma-derived therapies.
- Who is exposed:
- Plasma product manufacturers, blood banks, healthcare providers using plasma therapies
- For:
- Supply Chain Manager, Operations Director, Investment Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareTechnology shiftLong term (3+ years)
Brain-computer interfaces: the path to market
Map the regulatory and commercial pathways for brain-computer interface technologies to reach the market.
- Who is exposed:
- Neurotechnology companies, medical device manufacturers, rehabilitation centers, research institutions
- For:
- R&D Director, Product Manager, Investment Analyst
$250 delivered within 24 hours
- Medical Devices & HealthcareDemand shiftNear term (1-3 years)
Blood-based cancer screening: coverage and adoption
Understand the current coverage and adoption rates of blood-based cancer screening technologies.
- Who is exposed:
- Diagnostic companies, oncology practices, clinical laboratories, health insurers
- For:
- Market Access Manager, Product Manager, Medical Director
$250 delivered within 24 hours
- Medical Devices & HealthcareCyber & security riskNow (0-12 months)
Healthcare data breaches: which providers are most exposed?
Identify which healthcare providers are most vulnerable to data breaches to enhance security measures.
- Who is exposed:
- Hospitals, health systems, telehealth providers, electronic health record vendors
- For:
- Chief Information Security Officer, Compliance Officer, Risk Manager
$250 delivered within 24 hours
- Medical Devices & HealthcareRegulation & policyNow (0-12 months)
Telehealth weight-loss prescribers: regulatory risk
Assess the regulatory risks associated with telehealth platforms prescribing weight-loss medications.
- Who is exposed:
- Telehealth platforms, weight-loss clinics, pharmaceutical companies, digital health providers
- For:
- Legal Counsel, Compliance Officer, Business Development Lead
$250 delivered within 24 hours
- Medical Devices & HealthcareSupply chain riskNear term (1-3 years)
Biosensor component supply: how concentrated is it?
Understand the concentration of the biosensor component supply chain to identify potential vulnerabilities.
- Who is exposed:
- Medical device manufacturers, diagnostic companies, wearable technology companies
- For:
- Supply Chain Manager, Procurement Director, Product Development Lead
$250 delivered within 24 hours
- Semiconductors & ElectronicsSupply chain riskNear term (1-3 years)
HBM memory shortage: who is exposed through 2027?
Identify industries and companies exposed to the HBM memory shortage.
- Who is exposed:
- AI chip designers, data center operators, high-performance computing manufacturers
- For:
- Supply Chain Manager, Procurement Director, CTO
$250 delivered within 24 hours
- Semiconductors & ElectronicsGeopolitics & tradeNow (0-12 months)
Gallium and germanium export controls: an exposure map
Map the exposure of various industries to export controls on gallium and germanium.
- Who is exposed:
- Semiconductor manufacturers, solar panel producers, fiber optics companies, defense contractors
- For:
- Supply Chain Manager, Geopolitical Risk Analyst, Procurement Director
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentNear term (1-3 years)
Advanced packaging capacity: the real AI bottleneck?
Determine if advanced packaging capacity is a bottleneck for AI chip production.
- Who is exposed:
- AI chip designers, high-performance computing manufacturers, fabless semiconductor companies
- For:
- Operations Director, Supply Chain Manager, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsGeopolitics & tradeNow (0-12 months)
Chip-tool export controls to China: which equipment makers lose revenue?
Identify which equipment makers are losing revenue due to chip tool export controls to China.
- Who is exposed:
- Semiconductor equipment manufacturers, chip foundries, advanced materials suppliers
- For:
- International Sales Director, Strategy Lead, Government Affairs
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNear term (1-3 years)
China's mature-node build-out: price pressure on legacy chips
Assess the price pressure on legacy chips from China's mature-node manufacturing expansion.
- Who is exposed:
- Legacy chip manufacturers, automotive semiconductor suppliers, industrial electronics producers
- For:
- Product Manager, Sales Director, Market Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNear term (1-3 years)
The 2nm race: who has customers and capacity?
Understand the competitive landscape and capacity availability for leading-edge semiconductor manufacturing.
- Who is exposed:
- foundries, fabless chip designers, integrated device manufacturers
- For:
- CTO, Head of Procurement, Supply Chain VP
$250 delivered within 24 hours
- Semiconductors & ElectronicsPricing & cost pressureNear term (1-3 years)
Silicon carbide oversupply: price-collapse risk for EV power chips
Assess the risk of price collapse in silicon carbide due to potential oversupply and its impact on EV power chips.
- Who is exposed:
- silicon carbide manufacturers, EV component suppliers, automotive OEMs
- For:
- VP Purchasing, Head of Supply Chain, Product Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsGeopolitics & tradeNow (0-12 months)
Rare-earth magnet export controls: how exposed are motors and electronics?
Determine the exposure of motors and electronics industries to rare-earth magnet export controls.
- Who is exposed:
- motor manufacturers, electronics producers, automotive suppliers, wind turbine makers
- For:
- Supply Chain Director, Head of Sourcing, Risk Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentNow (0-12 months)
CHIPS Act fabs: which projects are on schedule and which slip?
Identify which CHIPS Act funded fab projects are progressing as planned and which face delays.
- Who is exposed:
- semiconductor manufacturers, construction companies, equipment suppliers
- For:
- VP Operations, Head of Government Affairs, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsTechnology shiftNear term (1-3 years)
Glass substrates: when do they replace organic substrates?
Anticipate the timeline for glass substrates replacing organic substrates in advanced packaging.
- Who is exposed:
- packaging companies, substrate manufacturers, advanced semiconductor producers
- For:
- CTO, Head of R&D, Product Development Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsTechnology shiftNear term (1-3 years)
Backside power delivery: who adopts first?
Identify the early adopters of backside power delivery technology in semiconductor manufacturing.
- Who is exposed:
- foundries, logic chip designers, semiconductor equipment makers
- For:
- CTO, Head of Process Engineering, Product Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNow (0-12 months)
Hybrid bonding equipment: winners in HBM and chiplets
Identify key players in hybrid bonding equipment gaining market share in HBM and chiplet applications.
- Who is exposed:
- semiconductor equipment manufacturers, advanced packaging providers, memory makers
- For:
- Head of Capital Equipment, VP Manufacturing, CTO
$250 delivered within 24 hours
- Semiconductors & ElectronicsPricing & cost pressureLong term (3+ years)
DRAM pricing cycle 2026-2027: up or down?
Forecast the direction of DRAM pricing for the upcoming cycle to inform purchasing and investment strategies.
- Who is exposed:
- DRAM manufacturers, PC OEMs, server manufacturers, smartphone makers
- For:
- Head of Procurement, Supply Chain VP, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsDemand shiftNow (0-12 months)
NAND flash: oversupply or AI-driven recovery?
Determine if NAND flash is facing oversupply or a recovery driven by artificial intelligence demand.
- Who is exposed:
- NAND flash manufacturers, data center operators, consumer electronics companies
- For:
- Head of Procurement, Supply Chain Manager, Product Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsDisruptionNear term (1-3 years)
Chiplets and UCIe: is an open chiplet market emerging?
Evaluate the emergence of an open chiplet market driven by UCIe and its implications for chip design.
- Who is exposed:
- CPU designers, ASIC developers, semiconductor foundries, IP vendors
- For:
- CTO, Head of Architecture, Product Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsGeopolitics & tradeNow (0-12 months)
Taiwan concentration risk: how exposed is your supply chain?
Quantify supply chain exposure to semiconductor manufacturing concentration in Taiwan.
- Who is exposed:
- electronics manufacturers, automotive OEMs, industrial equipment makers, IT companies
- For:
- Supply Chain VP, Risk Manager, Head of Procurement
$250 delivered within 24 hours
- Semiconductors & ElectronicsSupply chain riskNow (0-12 months)
Photoresist and specialty chemicals: supply concentration in Japan
Identify supply concentration risks for photoresist and specialty chemicals originating from Japan.
- Who is exposed:
- semiconductor manufacturers, chemical suppliers, equipment makers
- For:
- Supply Chain Director, Head of Sourcing, Risk Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsSupply chain riskNow (0-12 months)
Neon and specialty gases: supply risk for fabs
Assess the supply risk for neon and other specialty gases critical for semiconductor fabrication.
- Who is exposed:
- semiconductor fabs, gas suppliers, equipment manufacturers
- For:
- Supply Chain Manager, Head of Operations, Risk Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsTalent & labourNow (0-12 months)
Semiconductor talent shortage: where fabs cannot hire
Pinpoint specific regions and roles where semiconductor fabs face critical talent shortages.
- Who is exposed:
- semiconductor manufacturers, equipment suppliers, research institutions
- For:
- Head of HR, VP Operations, Talent Acquisition Lead
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentNow (0-12 months)
EUV lithography: tool backlog and pricing
Understand the backlog and pricing dynamics for EUV lithography tools.
- Who is exposed:
- foundries, advanced chipmakers, equipment suppliers
- For:
- VP Capital Equipment, Head of Procurement, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNear term (1-3 years)
RISC-V adoption: a threat to licensed CPU architectures?
Assess the threat of RISC-V adoption to established licensed CPU architectures.
- Who is exposed:
- CPU IP vendors, chip designers, embedded system developers
- For:
- CTO, Head of Product Strategy, IP Licensing Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsDemand shiftNow (0-12 months)
Automotive chips: inventory correction or another shortage?
Determine if the automotive chip market is undergoing an inventory correction or heading towards another shortage.
- Who is exposed:
- automotive OEMs, tier suppliers, semiconductor manufacturers
- For:
- Head of Supply Chain, VP Purchasing, Inventory Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsTechnology shiftNear term (1-3 years)
Power semiconductors for AI data centres: GaN versus SiC
Compare GaN and SiC power semiconductors for AI data centers to inform technology choices.
- Who is exposed:
- power semiconductor manufacturers, data center operators, AI hardware developers
- For:
- CTO, Head of Engineering, Product Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentNear term (1-3 years)
India's semiconductor incentives: which projects will produce?
Identify which semiconductor projects in India, supported by incentives, are likely to achieve production.
- Who is exposed:
- semiconductor manufacturers, equipment suppliers, government agencies
- For:
- VP Government Affairs, Head of Business Development, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentLong term (3+ years)
Japan's chip revival: a realistic timeline
Establish a realistic timeline for Japan's semiconductor industry revival and its global impact.
- Who is exposed:
- semiconductor manufacturers, equipment suppliers, regional governments
- For:
- VP Strategy, Head of Business Development, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentNow (0-12 months)
Europe's chip fabs: delays and cancellations
Track delays and cancellations of semiconductor fab projects across Europe.
- Who is exposed:
- semiconductor manufacturers, equipment suppliers, European governments
- For:
- VP Operations, Head of Government Affairs, Investment Analyst
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNear term (1-3 years)
Silicon photonics: which suppliers gain from optical I/O?
Identify key suppliers in silicon photonics benefiting from the shift to optical I/O.
- Who is exposed:
- optical component manufacturers, data center equipment providers, high-performance computing
- For:
- CTO, Head of Product Development, Sourcing Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsCapacity & investmentNow (0-12 months)
Memory makers' capex: who is expanding and who is cutting?
Understand which memory makers are expanding capital expenditure and which are reducing it.
- Who is exposed:
- DRAM manufacturers, NAND flash producers, equipment suppliers
- For:
- Investment Analyst, Head of Capital Planning, Supply Chain VP
$250 delivered within 24 hours
- Semiconductors & ElectronicsSupply chain riskNow (0-12 months)
300mm wafer supply: shortage or surplus?
Determine if the 300mm wafer market faces a shortage or a surplus.
- Who is exposed:
- semiconductor foundries, integrated device manufacturers, wafer suppliers
- For:
- Head of Procurement, Supply Chain Manager, Operations VP
$250 delivered within 24 hours
- Semiconductors & ElectronicsGeopolitics & tradeNow (0-12 months)
Semiconductor tariffs: exposure by product category
Identify product categories most exposed to new semiconductor tariffs and their impact.
- Who is exposed:
- semiconductor manufacturers, electronics assemblers, automotive industry, consumer electronics
- For:
- Head of Trade Compliance, Supply Chain VP, Risk Manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsGeopolitics & tradeNear term (1-3 years)
PCB production leaving China: where is capacity going?
It helps buyers understand where new PCB manufacturing capacity is emerging outside China.
- Who is exposed:
- PCB manufacturers, electronics assemblers, automotive electronics, industrial electronics
- For:
- Supply chain VP, procurement director, manufacturing head
$250 delivered within 24 hours
- Semiconductors & ElectronicsPricing & cost pressureNow (0-12 months)
Display panel price wars: LCD and OLED exposure
It helps buyers assess the impact of display panel price wars on their product costs and competitive positioning.
- Who is exposed:
- LCD manufacturers, OLED manufacturers, display component suppliers, consumer electronics
- For:
- Product manager, procurement director, strategy VP
$250 delivered within 24 hours
- Semiconductors & ElectronicsTechnology shiftNear term (1-3 years)
Quantum-safe hardware: chip migration deadlines
It helps buyers understand the timelines for migrating to quantum-safe hardware to meet future security standards.
- Who is exposed:
- Chip manufacturers, cybersecurity providers, government contractors, financial services
- For:
- CTO, security architect, product development head
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNow (0-12 months)
AI accelerator start-ups: who survives the funding squeeze?
It helps buyers identify which AI accelerator startups are best positioned to survive current funding challenges.
- Who is exposed:
- AI chip startups, venture capital firms, cloud providers, data center operators
- For:
- Investment director, corporate development VP, CTO
$250 delivered within 24 hours
- Semiconductors & ElectronicsSupply chain riskNear term (1-3 years)
Water stress at fabs: which sites are exposed?
It helps buyers identify semiconductor fabrication sites most vulnerable to water stress and potential disruptions.
- Who is exposed:
- Semiconductor fabs, equipment suppliers, regional governments, water utilities
- For:
- Operations VP, supply chain head, sustainability director
$250 delivered within 24 hours
- Semiconductors & ElectronicsCyber & security riskNow (0-12 months)
Counterfeit chips: risk in defence and automotive supply chains
It helps buyers understand the risks of counterfeit chips in critical supply chains and mitigation strategies.
- Who is exposed:
- Defense contractors, automotive manufacturers, electronics assemblers, supply chain logistics
- For:
- Supply chain VP, quality assurance head, risk management director
$250 delivered within 24 hours
- Semiconductors & ElectronicsTechnology shiftLong term (3+ years)
MicroLED: real commercialisation or delayed again?
It helps buyers determine the realistic commercialization timeline for MicroLED technology and its market impact.
- Who is exposed:
- Display manufacturers, consumer electronics, augmented reality, automotive displays
- For:
- Product development head, R&D director, strategy VP
$250 delivered within 24 hours
- Semiconductors & ElectronicsPricing & cost pressureNow (0-12 months)
Smartphone component costs: inflation from AI features
It helps buyers understand how AI features are driving up smartphone component costs and impacting profitability.
- Who is exposed:
- Smartphone manufacturers, component suppliers, consumer electronics, chip designers
- For:
- Procurement director, product manager, finance VP
$250 delivered within 24 hours
- Semiconductors & ElectronicsCompetitive threatNear term (1-3 years)
800G and 1.6T data-centre networking: the supplier race
It helps buyers identify leading suppliers in the race for 800G and 1.6T data center networking solutions.
- Who is exposed:
- Networking equipment providers, data center operators, cloud service providers, chip manufacturers
- For:
- CTO, network architect, product manager
$250 delivered within 24 hours
- Semiconductors & ElectronicsPricing & cost pressureNow (0-12 months)
Analog chips: price pressure from Chinese suppliers
It helps buyers assess the price pressure on analog chips from increasing competition from Chinese suppliers.
- Who is exposed:
- Analog chip manufacturers, industrial electronics, automotive electronics, power management
- For:
- Procurement director, product manager, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentNear term (1-3 years)
Small modular reactors: real projects versus announcements
It helps buyers distinguish between announced small modular reactor projects and those with real progress.
- Who is exposed:
- Nuclear power developers, energy utilities, engineering firms, government agencies
- For:
- Investment director, project development head, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentNow (0-12 months)
Green hydrogen project cancellations: who is exposed?
It helps buyers identify companies and industries exposed to green hydrogen project cancellations.
- Who is exposed:
- Green hydrogen developers, electrolyzer manufacturers, energy utilities, industrial gas companies
- For:
- Investment director, project development head, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyPricing & cost pressureNow (0-12 months)
China battery overcapacity: price impact on Western gigafactories
It helps buyers assess the impact of Chinese battery overcapacity on prices for Western gigafactories.
- Who is exposed:
- Battery manufacturers, EV makers, energy storage developers, raw material suppliers
- For:
- Procurement director, strategy VP, investment director
$250 delivered within 24 hours
- Future Tech & EnergyCompetitive threatNear term (1-3 years)
Sodium-ion batteries: a threat to LFP?
It helps buyers understand if sodium-ion batteries pose a significant threat to existing LFP battery technology.
- Who is exposed:
- Lithium-ion battery manufacturers, EV makers, energy storage developers, raw material suppliers
- For:
- R&D director, product development head, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftLong term (3+ years)
Solid-state batteries: a realistic commercial timeline
It helps buyers determine a realistic commercial timeline for solid-state battery technology.
- Who is exposed:
- Battery manufacturers, EV makers, consumer electronics, energy storage developers
- For:
- R&D director, product development head, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergySupply chain riskNow (0-12 months)
Grid transformer shortage: lead times and who is affected
It helps buyers understand the lead times for grid transformers and which entities are most affected by shortages.
- Who is exposed:
- Energy utilities, grid operators, industrial manufacturers, construction companies
- For:
- Procurement director, operations VP, infrastructure development head
$250 delivered within 24 hours
- Future Tech & EnergyPricing & cost pressureNow (0-12 months)
Critical mineral price swings: lithium, nickel and cobalt exposure
It helps buyers assess their exposure to price swings in critical minerals like lithium, nickel, and cobalt.
- Who is exposed:
- EV manufacturers, battery producers, electronics companies, mining companies
- For:
- Procurement director, supply chain VP, finance VP
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
EU carbon border adjustment (CBAM): which exporters pay?
It helps buyers identify which exporters will be subject to the EU carbon border adjustment mechanism.
- Who is exposed:
- Importers, exporters, steel manufacturers, aluminum producers, fertilizer producers, cement manufacturers
- For:
- Trade compliance manager, sustainability director, finance VP
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentNear term (1-3 years)
Direct air capture: are the offtake contracts real?
It helps buyers determine the authenticity and scale of direct air capture offtake contracts.
- Who is exposed:
- Direct air capture developers, carbon credit buyers, energy companies, industrial emitters
- For:
- Investment director, sustainability director, project development head
$250 delivered within 24 hours
- Future Tech & EnergyDemand shiftNear term (1-3 years)
Sustainable aviation fuel mandates: how big is the supply gap?
It helps buyers quantify the supply gap for sustainable aviation fuel given new mandates.
- Who is exposed:
- Airlines, fuel producers, aerospace manufacturers, biofuel companies
- For:
- Procurement director, sustainability director, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentNow (0-12 months)
Offshore wind cancellations: supply chain exposure
It helps buyers identify which parts of the supply chain are exposed to offshore wind project cancellations.
- Who is exposed:
- Offshore wind developers, turbine manufacturers, component suppliers, marine construction
- For:
- Investment director, project development head, supply chain VP
$250 delivered within 24 hours
- Future Tech & EnergyDemand shiftNow (0-12 months)
Heat pump demand slump: who is exposed?
It helps buyers understand which companies and industries are exposed to the heat pump demand slump.
- Who is exposed:
- Heat pump manufacturers, HVAC installers, building materials suppliers, energy utilities
- For:
- Sales director, product manager, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyDemand shiftNow (0-12 months)
EV demand slowdown: which suppliers are hit?
It helps buyers identify which suppliers are most affected by the slowdown in electric vehicle demand.
- Who is exposed:
- EV manufacturers, battery suppliers, charging infrastructure, automotive component suppliers
- For:
- Sales director, product manager, supply chain VP
$250 delivered within 24 hours
- Future Tech & EnergyCompetitive threatNear term (1-3 years)
EV charging consolidation: who survives?
It helps buyers identify which EV charging companies are best positioned to survive industry consolidation.
- Who is exposed:
- EV charging providers, energy utilities, automotive manufacturers, real estate developers
- For:
- Investment director, corporate development VP, strategy VP
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftLong term (3+ years)
Quantum computing: when will it threaten current encryption?
It helps buyers understand the timeline for when quantum computing will pose a threat to current encryption.
- Who is exposed:
- Cybersecurity providers, financial institutions, government agencies, IT infrastructure
- For:
- CTO, security architect, risk management director
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftNear term (1-3 years)
Post-quantum cryptography deadlines: who must migrate by when?
This helps buyers understand the urgency and scope of migrating to post-quantum cryptography to avoid future security vulnerabilities.
- Who is exposed:
- Software providers, hardware manufacturers, financial services, government contractors
- For:
- Chief Information Security Officer, Chief Technology Officer, Head of Compliance
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentLong term (3+ years)
Commercial space stations: funding and timeline risk
This helps buyers assess the financial viability and timeline risks associated with commercial space station projects.
- Who is exposed:
- Aerospace manufacturers, launch service providers, space tourism, research institutions
- For:
- Chief Financial Officer, Head of Business Development, Investment Analyst
$250 delivered within 24 hours
- Future Tech & EnergyCompetitive threatNear term (1-3 years)
Satellite broadband: the impact on telecom operators
This helps buyers understand the competitive impact of satellite broadband on their existing telecom operations and market share.
- Who is exposed:
- Fixed-line telecom operators, mobile network operators, internet service providers
- For:
- Chief Strategy Officer, Head of Product, Business Development Manager
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNear term (1-3 years)
Beyond-line-of-sight drone rules: commercial delivery reality
This helps buyers understand the regulatory landscape for beyond-line-of-sight drone operations and its impact on commercial delivery feasibility.
- Who is exposed:
- Logistics companies, e-commerce retailers, drone manufacturers, last-mile delivery
- For:
- Head of Operations, Supply Chain Director, Regulatory Affairs Manager
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyLong term (3+ years)
eVTOL air taxis: certification delays and cash burn
This helps buyers assess the risks associated with eVTOL air taxi certification delays and the financial implications of high cash burn.
- Who is exposed:
- Aerospace manufacturers, urban mobility providers, battery suppliers, software developers
- For:
- Chief Technology Officer, Head of Engineering, Investment Analyst
$250 delivered within 24 hours
- Future Tech & EnergyDemand shiftNow (0-12 months)
Industrial robot demand: China versus the rest of the world
This helps buyers understand the regional demand dynamics for industrial robots, particularly the role of China versus other markets.
- Who is exposed:
- Robot manufacturers, automation integrators, automotive industry, electronics manufacturing
- For:
- Chief Sales Officer, Head of Market Research, Business Development Manager
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftNear term (1-3 years)
3D printing in production: which industries have scaled it?
This helps buyers identify which industries have successfully integrated 3D printing into their production processes and scaled its use.
- Who is exposed:
- Aerospace, automotive, medical devices, consumer goods manufacturing
- For:
- Head of Manufacturing, Product Development Manager, Supply Chain Director
$250 delivered within 24 hours
- Future Tech & EnergyDemand shiftNear term (1-3 years)
Desalination: project pipelines in water-stressed regions
This helps buyers identify regions with significant desalination project pipelines to target new business opportunities.
- Who is exposed:
- Water utility companies, engineering firms, chemical suppliers, infrastructure developers
- For:
- Head of Infrastructure, Business Development Manager, Government Relations
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentLong term (3+ years)
Fusion energy: private funding versus milestones
This helps buyers understand the progress of fusion energy development by comparing private funding levels with key technological milestones.
- Who is exposed:
- Energy utilities, heavy industry, venture capital, government research institutions
- For:
- Chief Technology Officer, Investment Analyst, Head of Research and Development
$250 delivered within 24 hours
- Future Tech & EnergyCapacity & investmentNear term (1-3 years)
Enhanced geothermal: the new power deals
This helps buyers identify new power deals and partnerships in enhanced geothermal, indicating market growth and investment opportunities.
- Who is exposed:
- Power generators, energy developers, engineering firms, grid operators
- For:
- Head of Renewable Energy, Business Development Manager, Investment Analyst
$250 delivered within 24 hours
- Future Tech & EnergySupply chain riskLong term (3+ years)
Rare-earth recycling: can it reduce dependence on China?
This helps buyers evaluate the potential of rare-earth recycling to reduce reliance on primary rare-earth sources and geopolitical risks.
- Who is exposed:
- Electronics manufacturers, electric vehicle producers, defense contractors, mining companies
- For:
- Supply Chain Director, Head of Sustainability, Procurement Manager
$250 delivered within 24 hours
- Future Tech & EnergySupply chain riskNear term (1-3 years)
Copper shortage: the impact on electrification projects
This helps buyers understand the impact of potential copper shortages on the cost and feasibility of electrification projects.
- Who is exposed:
- Electric vehicle manufacturers, renewable energy developers, construction, electronics industry
- For:
- Supply Chain Director, Procurement Manager, Head of Project Development
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
PFAS bans: which materials and products must be replaced?
This helps buyers identify which materials and products containing PFAS must be replaced due to impending regulatory bans.
- Who is exposed:
- Chemical producers, consumer goods, electronics, automotive, textiles, medical devices
- For:
- Head of Regulatory Affairs, Product Development Manager, Supply Chain Director
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
Packaging EPR rules: cost exposure for brands
This helps buyers understand their financial exposure and compliance requirements under new Extended Producer Responsibility rules for packaging.
- Who is exposed:
- Consumer brands, food and beverage, personal care, e-commerce retailers
- For:
- Head of Sustainability, Chief Financial Officer, Regulatory Affairs Manager
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
Methane regulations: how exposed are oil and gas operators?
This helps buyers assess their exposure to new methane regulations and the potential costs of compliance and emissions reduction.
- Who is exposed:
- Upstream oil and gas operators, midstream pipeline companies, natural gas producers
- For:
- Head of Environmental, Health and Safety, Chief Operating Officer, Regulatory Affairs Manager
$250 delivered within 24 hours
- Future Tech & EnergySupply chain riskNear term (1-3 years)
HALEU nuclear fuel: the supply bottleneck
This helps buyers understand the current supply bottlenecks for HALEU nuclear fuel and their implications for advanced reactor deployment.
- Who is exposed:
- Nuclear power plant operators, advanced reactor developers, fuel fabricators, government agencies
- For:
- Head of Fuel Supply, Chief Technology Officer, Government Relations Manager
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftNear term (1-3 years)
Long-duration energy storage: which technologies win contracts?
This helps buyers identify which long-duration energy storage technologies are securing contracts and gaining market traction.
- Who is exposed:
- Grid operators, renewable energy developers, battery manufacturers, utility companies
- For:
- Head of Grid Modernization, Chief Technology Officer, Investment Analyst
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNear term (1-3 years)
Space debris rules: the cost for satellite operators
This helps buyers understand the financial implications and operational costs associated with new space debris mitigation regulations.
- Who is exposed:
- Satellite operators, launch service providers, aerospace manufacturers, insurance providers
- For:
- Chief Operating Officer, Head of Regulatory Affairs, Chief Financial Officer
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
Cultivated meat: approvals versus bans
This helps buyers understand the global regulatory landscape for cultivated meat, comparing market approvals with outright bans.
- Who is exposed:
- Meat producers, food manufacturers, alternative protein companies, restaurants
- For:
- Head of Regulatory Affairs, Product Development Manager, Chief Strategy Officer
$250 delivered within 24 hours
- Future Tech & EnergyDisruptionNow (0-12 months)
Vertical farming failures: what survives?
This helps buyers identify which vertical farming business models and technologies are proving sustainable amidst industry failures.
- Who is exposed:
- Vertical farming operators, agricultural technology providers, fresh produce suppliers, real estate developers
- For:
- Chief Executive Officer, Investment Analyst, Head of Business Development
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNear term (1-3 years)
EU digital product passports: which products need them, and by when?
This helps buyers identify which products will require EU digital product passports and their implementation timelines.
- Who is exposed:
- Electronics manufacturers, textile industry, battery producers, packaging companies
- For:
- Head of Compliance, Supply Chain Director, Product Development Manager
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
Right-to-repair laws: the impact on device makers
This helps buyers understand the impact of right-to-repair laws on their product design, service models, and revenue streams.
- Who is exposed:
- Device manufacturers, electronics retailers, automotive industry, appliance makers
- For:
- Head of Legal, Product Development Manager, Chief Operating Officer
$250 delivered within 24 hours
- Future Tech & EnergyRegulation & policyNow (0-12 months)
NIS2 cyber rules: who must comply, and what it costs
This helps buyers identify if they must comply with NIS2 cyber rules and estimate the associated compliance costs.
- Who is exposed:
- Critical infrastructure operators, digital service providers, public administration, healthcare
- For:
- Chief Information Security Officer, Head of Compliance, Legal Counsel
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftLong term (3+ years)
6G spectrum and timelines: where investment goes
This helps buyers understand the future spectrum allocations and investment timelines for 6G technology development.
- Who is exposed:
- Telecom operators, network equipment vendors, semiconductor manufacturers, research institutions
- For:
- Chief Technology Officer, Head of Research and Development, Investment Analyst
$250 delivered within 24 hours
- Future Tech & EnergyTechnology shiftNear term (1-3 years)
Autonomous trucking: which routes go driverless first?
This helps buyers identify which trucking routes are most likely to adopt autonomous technology first, informing strategic planning.
- Who is exposed:
- Trucking companies, logistics providers, automotive manufacturers, technology developers
- For:
- Head of Operations, Supply Chain Director, Chief Technology Officer
$250 delivered within 24 hours
Viewpoints are prepared after your order from dated public sources and our market model, following our research method: reported facts are cited, estimates are labelled, and our assessment is marked as such. Need a topic that is not listed? Ask for it.